Answers are grounded in this paper and cite their sources.
EDITOR-Endometrial cancer (EC) is the second most common malignancy in the hereditary non-polyposis colorectal cancer (HNPCC) syndrome. In a recent large study, cumulative cancer incidences by the age of 70 in HNPCC mutation carriers were: colorectal 82%, endometrial 60%, gastric 13%, and ovarian 12%. 2 Interestingly, in female mutation carriers the incidence of endometrial cancer (60%) exceeded that of colorectal cancer (CRC) (54%), as had been suggested earlier. 2 3 Predisposition to HNPCC is the result of germline mutations in the mismatch repair genes. Detectable mutations in the two major genes, MLH1 and MSH2, account for some 3% of all colorectal cancers. 5 One might therefore assume that a similar proportion of all endometrial cancer patients would have such mutations; however, in a number of studies addressing this question, extremely few germline mutations have been found. Summarising the studies by Katabuchi et al, In these studies, mutations were sought in all patients whose tumours were microsatellite instability (MSI) positive.
No takes yet. Share an insight, caveat, or question.
Robert B. Chadwick (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: